Press release
New All-Natural Supplement Proven to Help Prevent and Heal Liver Conditions
Tokyo, Japan, June 3rd, 2017 -- Highly-regarded company Kyotsujigyo Inc. recently introduced Yojyo Henshi Ko to markets outside of Japan, offering a natural-based liver supplement that is clinically proven to improve liver health.Yojyo Henshi Ko, known as YHK ( http://www.yhktherapy.com/en/what-is-yhk/ ), has a patented formula specifically geared toward being as natural as possible. The formula consists of the following powerful herbs: panax pseudo ginseng, euccommia ulmoides, licorice root and rhizoma polygonati. These ingredients are known in nature to have strong anti-oxidant and healing effects in the body. “Yojyo Henshi Ko is the liver therapy of nature,” said Kyotsujigyo Hong Kong Branch Manager James Ma. “Our company has more than 25 years of experience in inventing healing supplements, and YHK is one that is specifically designed for liver recovery.”
With more than 30 different clinical scientific studies conducted and many research papers published, YHK is the most advanced liver protection supplement currently available. The scientific-based supplement holds patents in the United States, Canada, Japan, Europe and China. “Our product is suitable for people with all kinds of liver problems and conditions, especially for those who have chronic liver problems,” Ma said.
Published research data collected by the U.S. National Library of Medicine (PubMed.gov) indicates that YHK can help treat and prevent NASH. NASH, Non-Alcoholic Steatohepatitis (a type of fatty liver disease), is becoming increasingly common for people who do not consume large amounts of alcohol. It is predicted to be the leading cause of liver transplants by the year 2020. This condition is caused by liver inflammation and damage due to the buildup of fat in the liver. The damage causes the liver to not work as well as it should. Additionally, NASH can cause scarring on the liver and lead to cirrhosis. Clinical data shows that YHK can strengthen and recover liver function and lower the ALT liver enzyme level.
Currently, there is no known medical treatment for NASH, which makes YHK a unique and viable option for people who suffer from liver problems. “When YHK is taken as directed, enzyme levels will lower and normalize,” said Ma, explaining YHK’s immediate results. “More than ninety percent of chronic liver disease patients saw liver improvement after 14 days of use.”
YHK has received a great deal of positive consumer feedback on its website. Customer reviews claim that the supplement does precisely what it guarantees to do, produces life-changing results, and improves health and liver function. Since it is composed of all-natural ingredients, YHK is safe to take with other medicines.
Professionally-recommended, YHK can strengthen and repair liver cells; recover and protect liver function; help the liver function properly; and prevent further damage—all with no health side effects. It is considered to be safe for long-term use.
Consumers can also experience the following benefits when taking YHK as suggested:
* Improved energy level
* Better appetite
* Improved sleep
* Improved skin
* Reduced side effects from other medications.
* Enhanced immune system
* Reduce risk of liver cancer
Kyotsujigyo was founded in the early 90’s by S.H. Sha, a Musashino University professor who specialized in health maintenance, anti-aging and disease prevention, and it is committed to helping people improve and maintain their health. The company has expertise in Japanese Kampo Medicine and many of its research work is listed in the U.S. National Library of Medicine. In addition, Kyotsujigyo is a member of the Massachusetts Institute of Technology Liaison Program.
For more information about Kyotsujigyo or YHK, visit http://www.kyotsujigyo.net or http://www.yhktherapy.com
Press & Media Contact:
James Ma
Hong Kong Branch Manager
Kyotsujigyo
Tokyo, Japan
+852 6702 2602
mail@kyotsujigyo.net
http://www.yhktherapy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New All-Natural Supplement Proven to Help Prevent and Heal Liver Conditions here
News-ID: 562683 • Views: …
More Releases for YHK
On2 Technologies Licenses VP6 Video Decoder Technology to videantis
CLIFTON PARK, NY (September 22, 2009) - On2 Technologies (NYSE Amex: ONT) announced today that videantis has licensed its VP6 video decoder source code for implementation in the videantis v-MPx programmable processor platform.
videantis makes flexible IP cores for advanced multimedia applications. With its optimized proprietary instruction set and parallel processing capabilities, the videantis v-MPx platform supports the implementation of high-performance video and image processing tasks using software updates instead…
videantis announces full HD 1080p video codec IP solution for mobile and consume …
Low-power multi-core design enables H.264/AVC baseline profile 1080p encoding and H.264/AVC high profile 1080p video decoding with multi-standard extensibility
Hannover, Germany -- October 06, 2008 -- videantis GmbH, a leading provider of programmable video engines, today announced the addition of the new v-MP4180HDX 1080p full HD video encode and decode IP to its growing portfolio of scalable multi-standard video IP solutions.
By combining a powerful, programmable high definition stream unit with multiple…
videantis introduces new scalable video solutions up to HD for mobile devices
Integrated stream unit enables high-quality encoding, high-bitrate decoding on ultra-small silicon area with minimum load on host CPU
Hannover, Germany -- April 30, 2008 -- videantis GmbH, a leading provider of programmable video engines, today announced the addition of the new v-MP20x0MOB product line of scalable video solutions to its growing portfolio of multi-standard video IP solutions. By combining powerful video engines with a programmable stream unit, the v-MP20x0MOB solution…